Refine
Document Type
- Doctoral Thesis (5)
Language
- English (5) (remove)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- Streptococcus pneumoniae (5) (remove)
Institute
- Institut für Mikrobiologie - Abteilung für Genetik & Biochemie (5) (remove)
Streptococcus pneumoniae (pneumococci) and Staphylococcus aureus (S. aureus) are human-specific commensals of the upper respiratory tract. Every individual is asymptomatically colonized with both bacteria at least once in their life-time. The opportunistic pathogens can affect further organs and invade into deeper tissue. The occupation of normally sterile niches of the human body with the bacteria can lead to local infections such as sinusitis, otitis media and abscesses, or to life-threatening diseases like pneumonia, meningitis or sepsis. A strong interaction between the bacterium and the respiratory epithelial cells is a prerequisite for a successful colonization. This interaction is ensured by bacterial surface proteins, so called adhesins. The binding of the adhesins to the epithelial lineage occurs predominantly indirectly via components of the extracellular matrix (ECM), but also directly to cellular receptors. Pneumococci and S. aureus bind to various ECM glycoproteins, amongst others: fibronectin, fibrinogen, vitronectin, and collagen. Also binding of both pathogens to human thrombospondin-1 has been described. Thrombospondin-1 is mainly stored in the α-granula of thrombocytes (platelets) and released into the circulation upon activation. However, thrombospondin-1 is also produced and secreted by other cell types like endothelial cells, macrophages, and fibroblasts, which gets subsequently incorporated as component into the ECM. So far, no thrombosponin-1-binding adhesins of pneumococci were identified. PspC, Hic, and PavB are important surface-localized virulence factors, which were shown to interact with human ECM and plasma proteins. PspC and Hic bind to vitronectin and factor H, which inhibits the complement cascade of the human immune system. PavB interacts with fibronectin and plasminogen, and a pavB-deficient mutant of S. pneumoniae showed diminished capacity in colonization in a mouse model. Among the surface proteins of S. aureus, only Eap was identified as thrombospondin-1-binding adhesin. Beyond colonization, pneumococci and S. aureus can enter the blood circulation, interact with platelets, and cause their activation. The aggregation of platelets, especially initiated by S. aureus, plays an important role in the clinic, because most of the septic patients develop thrombocytopenia. Surface localized factors of
S. pneumoniae triggering platelet activation are unknown to date. In contrast, few proteins of S. aureus with potential to activate platelets, including Eap, were identified previously.
This study identified the surface proteins PavB, PspC, and Hic of S. pneumoniae as specific ligands of the human thrombospondin-1. Flow cytometric, surface plasmon resonance spectroscopic and immunological analyses revealed interactions between the pneumococcal proteins and soluble as well as immobilized thrombospondin-1. The use of specific pneumococcal deletion mutants verified the importance of the three virulence factors as binding partners of soluble thrombospondin-1. The results suggest that pneumococci are capable of acquiring soluble thrombospondin-1 from blood as well as utilizing immobilized glycoprotein of the ECM as substrate for adhesion. Furthermore, the thrombospondin-1-binding domain within the pneumococcal proteins was analyzed by use of recombinant fragments of PavB, PspC, and Hic. The binding capacity of thrombospondin-1 increased proportionally with the amount of repetitive sequences in PavB and PspC, and the length of the α-helical region within the Hic molecule. The binding behavior of thrombospondin-1 towards PavB and PspC is comparable with that of the ECM proteins vitronectin and fibronectin, but is unique towards Hic.
The localization of the binding domain of the adhesins within the thrompospondin-1 molecule occurred via use of glycosaminoglycans as competitive inhibitors for the interaction. The results suggest that the pneumococcal proteins Hic and PspC target the identical binding region within thrombospondin-1, which differs from the binding domain for PavB. However, all three virulence factors seem to bind in the N-terminal part of thrombospondin-1.
Two-dimensional gel electrophoresis, thrombospondin-1 overlay assay and subsequent mass spectrometric analysis identified AtlA of S. aureus as a surface localized interaction partner of human thrombospondin-1. Moreover, a vitronectin binding activity for AtlA was determined. Immunological and surface plasmon resonance binding studies with recombinant AtlA fragments revealed that interactions with both matrix proteins is mediated via the C-terminal located repeats R1R2 of the AtlA amidase domain. Binding of thrombospondin-1 and vitronectin occurred not simultaneously, due to a competitive inhibition.
The second part of the study focused on the activation of human platelets by recombinant pneumococcal and staphylococcal proteins. In total, 28 proteins of S. pneumoniae and 52 proteins of S. aureus were incubated with human platelets. The activation of the cells was detected by flow cytometry using the activation markers P-selectin and the dimerization of the integrin αIIbβIII. The proteins CbpL, PsaA, PavA, and SP_0899 of S. pneumoniae induced platelet activation, however, the detailed mechanism has to be deciphered in further studies. Furthermore, the secreted proteins CHIPS, FLIPr, and AtlA of S. aureus were discovered as inductors for the activation of platelets. In addition, the domains of AtlA and Eap, crucial for platelet activation, were narrowed down. Interestingly, CHIPS, FLIPr, and Eap were described as inhibitors of neutrophil recruitment. Platelets are recently recognized as immune cells, due to the expression of immune receptors. The data obtained in this study highlight a comprehensive spectrum of effects of the S. aureus proteins towards different type of immune cells. Besides the activation of platelets in suspension buffer and plasma, the aggregation of platelets in whole blood was triggered by the proteins CHIPS, AtlA, and Eap. These results suggest a contribution of the proteins during the S. aureus-induced infectious endocarditis. Secretion of the platelet activating virulence factors, which were identified within this study, might represent a pathogenic strategy during S. aureus infection in which a direct contact between S. aureus and platelets is not required or even avoided.
In conclusion, PavB, PspC, and Hic of S. pneumoniae and AtlA of S. aureus were identified as interaction partners of human thrombospondin-1. Furthermore, CHIPS, FLIPr, AtlA, and Eap were characterized as platelet activators. This study provides candidates for the development of protein-based vaccines, to prevent bacterial colonization and to neutralize secreted pathogenic factors.
The influence of regulatory proteins on the physiology and virulence of Streptococcus pneumoniae
(2015)
In conclusion, this work identifies the regulator ArgR2 as activator of the S. pneumoniae TIGR4 arginine deiminase system and arginine-ornithine transporter ArcD, which is needed for uptake of the essential amino acid arginine. Although ArgR2 activates ArcD expression and uptake of arginine is required to maintain pneumococcal fitness, the deficiency of ArgR2 increases TIGR4 virulence under in vivo conditions, suggesting that other factors regulated by ArgR2 counterbalance the reduced uptake of arginine by ArcD. Thus this works illustrates that the physiological homeostasis of pneumococci is complex and that ArgR2 plays a key role in maintaining bacterial fitness. Moreover, Rex was identified as a regulator of housekeeping genes including genes encoding glycolytic enzymes. In vitro studies and gene expression analyses suggested that the regulator Rex does not have an influence on the physiology of S. pneumoniae. However, a co-infection experiment demonstrated that Rex is involved in maintaining pneumococcal fitness and robustness under in vivo conditions.
Streptococcus pneumoniae (the pneumococcus) is a harmless resident of the human nasopharyngeal cavity, and, in general, every individual is likely to be colonized asymptomatically at least once during life. However, under certain conditions, the bacterium can spread to other tissues and organs causing local, non-invasive infections but also lifethreatening, invasive diseases. Pneumococcal carriage and infection is a highly regulated interplay between pathogen- and host-specific factors and the intimate contact of S. pneumoniae with the surface of the nasopharynx is the crucial step in pneumococcal pathogenesis. Pneumococcal adherence to the respiratory epithelium is mediated by surface-exposed adhesins. These adhesins engage host cell receptors either directly or indirectly by recognizing glycoproteins of the extracellular matrix (ECM) including structural components, such as collagens, laminins, and fibronectins, as well as plasma-derived ECM modulators, like vitronectin and Factor H. Pneumococcal surface protein C (PspC) is a surface-exposed protein and important virulence factor of S. pneumoniae. The multifunctional PspC protein promotes pneumococcal adherence to host cells by interacting with the secretory component of the human polymeric Immunoglobulin receptor of respiratory cells. In addition, PspC facilitates pneumococcal immune evasion by recruiting the complement inhibitor proteins C4b-binding protein (C4BP) and Factor H. Moreover, Factor H bound to the pneumococcal surface promotes bacterial adhesion to human epithelial and endothelial cells. S. pneumoniae also interacts with the human glycoprotein vitronectin. In plasma, monomeric vitronectin regulates thrombosis, fibrinolysis and the terminal complement cascade, while it additionally mediates cell-matrix interactions, cell adhesion and migration in the ECM. It was shown that multimeric, ECM-associated vitronectin facilitates pneumococcal adherence to respiratory epithelial cells. In addition, the interaction of pneumococci with vitronectin promotes their uptake by mucosal epithelial cells via the engagement of the integrin αvβ3 receptor and activation of intracellular signaling pathways culminating in cytoskeletal rearrangements. This study aims to identify and characterize the surface-exposed protein(s) that mediate binding of pneumococci to vitronectin and to elucidate the impact of vitronectin on pneumococcal pathogenesis beyond its function as molecular bridge between pneumococcus and host. Flow cytometric, immunosorbent and surface plasmon resonance experiments revealed that PspC is a vitronectin-binding protein of S. pneumoniae. The specificity of the interaction with vitronectin was confirmed using recombinant PspC proteins and Lactococcus lactis heterologously expressing PspC on their surface. Factor H did not hinder vitronectinbinding to PspC indicating that vitronectin recognizes the central part of PspC. Secretory IgA inhibited but not completely prevented vitronectin-binding to PspC, strongly suggesting that vitronectin binds near, but not directly to, the SC-binding region within the R domain(s) of PspC. In addition, PspC proteins comprising two R domains bound with higher affinity to vitronectin than PspC containing only one R domain, indicating that two interconnected R domains are required for efficient vitronectin-binding. Despite the sequential and structural differences to classical PspC, the PspC-like protein Hic specifically interacted with vitronectin with similar affinity than PspC containing two linked R domains. Binding studies confirmed that Factor H interacts with the very N-terminal region of Hic showing high sequence homology to classical PspC proteins, while vitronectin recognizes an adjacent region in the N-terminal region of Hic. The studied PspC proteins bound to both soluble and immobilized vitronectin, and the C-terminal heparin-binding domain (HBD3) was identified as PspC-binding motif in soluble vitronectin. However, in its immobilized form, vitronectin likely exposes additional binding sites for PspC since a region N-terminally to the identified HBD3 conferred binding of PspC. Vitronectin inhibits the terminal complement pathway, thereby preventing proinflammatory immune reactions and tissue damage. In general, pneumococci are protected from opsonization and MAC-dependent lysis by their capsule. However, pneumococci in close contact to human cells can become susceptible to complement attack due to reduced amounts of capsule. In addition, they can be severely affected by TCC-induced inflammatory responses. Vitronectin bound to PspC significantly inhibited the formation of terminal complement complexes. Thus, the interaction of PspC with vitronectin might aid in immune evasion of S. pneumoniae by inhibiting complement-mediated lysis and/or suppressing proinflammatory events. In conclusion, the results revealed the multifunctional PspC and Hic as vitronectin-binding proteins and proposed a novel role for the specific interaction of S. pneumoniae with vitronectin in regulating the complement cascade, beside its function as molecular bridge to the respiratory epithelium.
Streptococcus pneumoniae (pneumococci) are Gram-positive cocci and commensals of the human upper respiratory tract. Pneumococcal pathogenesis requires adherence to host cells and dissemination through cellular barriers and to evade host defense mechanisms. The Pneumococcal surface protein C (PspC) is an important virulence factor which has a crucial role in pneumococcal adhesion to host cells and immune evasion by manipulating the host complement system. To elucidate the pneumococcal adherence and uptake mechanism via factor H glycosaminoglycans (dermatan sulfate and heparin) were employed as competitive inhibitors in infection experiments with epithelial cells or human polymorphonuclear leukocytes (PMNs). Glycosaminoglycans significantly inhibited the FH mediated pneumococcal adherence and subsequent invasion to host epithelial cells. Furthermore, the short consensus repeats of FH which promotes the adhesion of pneumococci to host cells were identified by blocking experiments with domain mapped antibodies for specific regions of FH. Moreover, this study indicates that FH acts as adhesion molecule via cellular receptors recognized as integrin CR3 on human PMNs. Binding of Factor H loaded pneumococci to integrins CR3 was assessed by flow cytometry. Pneumococci coated with Factor H showed a significantly increased association with PMNs. This interaction was blocked by anti-CR3 antibodies and Pra1. This project further aims to study mechanisms of pneumococcal endocytosis by host cells, their intracellular fate, and the pathogen induced host cell signal transduction cascades including the calcium signaling upon pneumococcal infection of host cells via the PspC-hpIgR interaction. To assess now the role of protein tyrosine kinases (PTKs) during pneumococcal infection via PspC, cell culture infections were performed in presence of pharmacological inhibitors of PTKs and MAPKs or by employing genetic interference techniques. Blocking the function of Src or ER1/2 and JNK and genetic-knock down of Src and FAK reduced significantly internalization of pneumococci. These data indicated the importance of a coordinated signaling between Src PTKs, ERK1/2, and JNK during PspC-pIgR-mediated uptake of pneumococci by host epithelial cells. The impact of host cells intracellular calcium concentrations on pneumococcal PspC-hpIgR mediated internalization was studied. Intracellular calcium measurement of epithelial cells performed in the presence of pneumococci suggested a calcium influx in host epithelial cells and importantly this calcium influx was PspC- hpIgR specific as pspC-deficient pneumococci were unable to mediate calcium mobilization in host cells. The increase in intracellular calcium [Ca2+]i was dependent on phospholipase C as pretreatment of cells with a phospholipase C-specific inhibitor abolished the increase in [Ca2+]i. Furthermore, role of host intracellular calcium concentrations during pneumococcal internalization was demonstrated by employing specific pharmacological inhibitors and calcium chelators in epithelial cell culture infection assays. The results revealed that elevated host cells calcium concentrations diminished pneumococcal internalization while lower calcium concentration in host epithelial cells promoted pneumococcal uptake. This study further demonstrates that dynamin, clathrin and caveolin play a key role during pneumococcal endocytosis into host cells via PspC-hpIgR. The use of specific pharmacological inhibitors or genetic interference approaches against dynamin, clathrin and caveolin in epithelial cell culture infection assays significantly blocked pneumococcal uptake. Furthermore, confocal microscopy revealed that pneumococci co-localize with clathrin. At later stages of the infection the pathogen is sorted to early, late and recycling endosomes as indicated by co-localization of pneumococci with endosomal markers such as Rab5, Rab4, Rab 7, and Lamp1. In order to get further insights into PspC-hpIgR mediated uptake mechanisms, a chimeric PspC was constructed and expressed heterologously on the surface of Lactococcus lactis. Immunofluorescence staining, immunoblot and flow cytometric analysis of L. lactis confirmed the expression of PspC on the bacterial surface. Moreover the ability of recombinant lactococci expressing PspC to adhere to and to invade pIgR-expressing epithelial cells confirmed the functional activity of PspC when exposed on the lactococcal surface. PspC expressing lactococci confirmed the specificity of PspC-hpIgR mediated endocytosis in host epithelial cells as PspC deficient lactococci were not taken up by these host cells. Confocal microscopic analysis demonstrated that only PspC expressing lactococci were sorted to early, late and recycling endosomes, similar to the intracellular fate of S. pneumoniae.
Streptococcus pneumoniae, more commonly known as the pneumococcus, is a Gram-positive bacterium colonizing the human upper respiratory tract as a commensal. However, these apparently harmless bacteria have also a high virulence potential and are known as the etiologic agent of respiratory and life-threatening invasive diseases. Dissemination of pneumococci from the nasopharynx into the lungs or bloodstream leads to community-acquired pneumonia, septicaemia and meningitis. Pneumococcal diseases are treated with antibiotics and prevented with polysaccharide-based vaccines. However, due to the increase of antibiotic resistance and limitations of the current vaccines, the burden of diseases remains high. Interactions of pneumococci with soluble host proteins or cellular receptors are crucial for adherence, colonization, transmigration of host barriers and immune evasion. The pneumococcal surface-exposed proteins are the main players involved in this host-pathogen interaction. Therefore, combating pneumococcal transmission and infections has emphasized the need for a new generation of immunogenic and highly protective pneumococcal vaccines, based on surface-exposed adhesins virtually expressed by all pneumococcal strains and serotypes. The genomic analysis of S. pneumoniae strains helped to identify pneumococcal virulence factors such as pili, PsrP and PavB, which have been demonstrated to interact with human proteins playing an important role during the pathogenic process of pneumococci, and are currently considered as new potential vaccine candidates against S. pneumoniae. A subclass of pneumococcal strains produces pili that are encoded by the pathogenicity islet pilus islet-1 (rlrA islet) and/or the pilus islet-2. Both types of pili are implicated in bacterial adherence to host cells. A further pathogenicity islet encoded protein is PsrP. The presence of the psrP-secY2A2 islet correlated positively with the ability of pneumococci to cause invasive pneumococcal diseases. Recent studies indicated that PsrP is a protective adhesin interacting with keratin 10 on lung epithelial cells. In this study, the genomic loci of the pneumococcal virulence factors pili, PsrP and PavB were molecularly analyzed and used as molecular markers for molecular epidemiology studies of S. pneumoniae. The genotyping results obtained here showed the impact of the PCV7 immunization of children, started in July 2006, on the distribution of these pneumococcal virulence factors among clinical isolates in Germany. These findings gave more insights into the role of pili, PsrP and PavB in pneumococcal pathogenesis and may strongly support the idea of including these pneumococcal constituents in a broad coverage protein-based vaccine against pneumococcal infections produced by invasive serotypes in the future. The mature PavB protein contains a variable number of repetitive sequences referred to as the Streptococcal Surface Repeats (SSURE). PavB has been demonstrated to interact with fibronectin and plasminogen in a dose-dependent manner and it was identified as a surface-exposed adhesin with immunogenic properties, which contributes to pneumococcal colonization and respiratory airways infections. The complete molecular analysis performed here for PavB, allowed to know more accurately its structure and to estimate the real number of SSURE units in different pneumococcal strains. With these findings, a new primary sequence-based structural model was constructed for the PavB protein and its SSURE domain, and, at least for TIGR4, the complete pavB gene and PavB protein sequences with five SSURE units was reported in the GenBank database of the NCBI website. Due to its immediate neighborhood on the pneumococcal genome with the tcs08 genes, PavB is likely linked with this pneumococcal TCS. Here, a significant reduction of the PavB protein expression was observed in delta-tcs08-mutant strains, which may strongly suggest that the TCS08 does play a role in pneumococcal virulence and metabolisme, as further observed in growth behaviour experiments carried out with the TCS08-deficient mutants, cultured in chemically defined medium. Despite several studies suggest that the molecular mechanism underlying the bacterial signal transduction is very sophisticated, the majority of reports in prokaryotic TCS, including those for S. pneumoniae, are still focused in single cognate pairs. The pneumococcal genome encodes 14 TCSs and an orphan response regulator. It is obvious that TCS pathways are often arranged into complex circuits with extensive cross-regulation at a variety of levels, thereby endowing cells with the ability to perform sophisticated information processing tasks. This study established also the experimental and molecular bases for the construction of a comprehensive genome-wide interaction map of the complex TCS pathways for its application in the gene regulation of pneumococcal virulence factors.